J&J announces Tecvayli-Darzalex combo approval from FDA for multiple myeloma
The approval was supported by data from the ongoing Phase III MajesTEC-3 study.
Drug Development
Liberate Bio gains licences for myeloid-specific CAR design patents
CordenPharma leases space at Flatiron Park for peptides development
Affinia receives FDA fast track designation for AFTX-201
Aspire Biopharma and Microsize collaborate for alprazolam powder formulation
Esperion to acquire Corstasis for cardiovascular franchise expansion
Rallybio to acquire Candid Therapeutics
Kairos Pharma signs deal for Celyn Therapeutics’ CL-273
